ID   SDCB1_RAT               Reviewed;         300 AA.
AC   Q9JI92;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   24-JUL-2024, entry version 153.
DE   RecName: Full=Syntenin-1;
DE   AltName: Full=Syndecan-binding protein 1;
GN   Name=Sdcbp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH SDCBP2 AND NFASC.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=11152476; DOI=10.1074/jbc.m010647200;
RA   Koroll M., Rathjen F.G., Volkmer H.;
RT   "The neural cell recognition molecule neurofascin interacts with syntenin-1
RT   but not with syntenin-2, both of which reveal self-associating activity.";
RL   J. Biol. Chem. 276:10646-10654(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11179419; DOI=10.1091/mbc.12.2.339;
RA   Zimmermann P., Tomatis D., Rosas M., Grootjans J.J., Leenaerts I.,
RA   Degeest G., Reekmans G., Coomans C., David G.;
RT   "Characterization of syntenin, a syndecan-binding PDZ protein, as a
RT   component of cell adhesion sites and microfilaments.";
RL   Mol. Biol. Cell 12:339-350(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH PTPRJ.
RX   PubMed=11434923; DOI=10.1016/s0014-5793(01)02580-7;
RA   Iuliano R., Trapasso F., Sama I., Le Pera I., Martelli M.L., Lembo F.,
RA   Santoro M., Viglietto G., Chiariotti L., Fusco A.;
RT   "Rat protein tyrosine phosphatase eta physically interacts with the PDZ
RT   domains of syntenin.";
RL   FEBS Lett. 500:41-44(2001).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Multifunctional adapter protein involved in diverse array of
CC       functions including trafficking of transmembrane proteins, neuro and
CC       immunomodulation, exosome biogenesis, and tumorigenesis. Positively
CC       regulates TGFB1-mediated SMAD2/3 activation and TGFB1-induced
CC       epithelial-to-mesenchymal transition (EMT) and cell migration in
CC       various cell types. May increase TGFB1 signaling by enhancing cell-
CC       surface expression of TGFR1 by preventing the interaction between TGFR1
CC       and CAV1 and subsequent CAV1-dependent internalization and degradation
CC       of TGFR1. In concert with SDC1/4 and PDCD6IP, regulates exosome
CC       biogenesis. Regulates migration, growth, proliferation, and cell cycle
CC       progression in a variety of cancer types. In adherens junctions may
CC       function to couple syndecans to cytoskeletal proteins or signaling
CC       components. Seems to couple transcription factor SOX4 to the IL-5
CC       receptor (IL5RA). May also play a role in vesicular trafficking. Seems
CC       to be required for the targeting of TGFA to the cell surface in the
CC       early secretory pathway. {ECO:0000250|UniProtKB:O00560}.
CC   -!- SUBUNIT: Monomer and homodimer (PubMed:11152476). Interacts with NFASC
CC       and SDCBP2 (PubMed:11152476). Interacts with PTPRJ (PubMed:11434923).
CC       Interacts with SDC1, SDC2, SDC3, SDC4, NRXN2, EPHA7, EPHB1, NF2 isoform
CC       1, TGFA and IL5RA (By similarity). Interacts with PDCD6IP. Forms a
CC       complex with PDCD6IP and SDC2. Interacts (via C-terminus) with TGFBR1
CC       (By similarity). Binds to FZD7; this interaction is increased by
CC       inositol trisphosphate (IP3) (By similarity). Interacts with SMO (By
CC       similarity). {ECO:0000250|UniProtKB:O00560,
CC       ECO:0000250|UniProtKB:O08992, ECO:0000269|PubMed:11152476,
CC       ECO:0000269|PubMed:11434923}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion
CC       {ECO:0000250|UniProtKB:O00560}. Cell junction, adherens junction
CC       {ECO:0000250|UniProtKB:O00560}. Cell membrane
CC       {ECO:0000250|UniProtKB:O00560}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:O00560}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:O00560}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:O00560}. Nucleus {ECO:0000250|UniProtKB:O00560}.
CC       Melanosome {ECO:0000250|UniProtKB:O00560}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:O00560}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:O00560}. Secreted, extracellular exosome
CC       {ECO:0000250|UniProtKB:O00560}. Membrane raft
CC       {ECO:0000250|UniProtKB:O00560}. Note=Mainly membrane-associated.
CC       Localized to adherens junctions, focal adhesions and endoplasmic
CC       reticulum. Colocalized with actin stress fibers. Also found in the
CC       nucleus. Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV. Associated to the plasma membrane in the presence
CC       of FZD7 and phosphatidylinositol 4,5-bisphosphate (PIP2) (By
CC       similarity). {ECO:0000250|UniProtKB:O00560}.
CC   -!- PTM: Phosphorylated on tyrosine residues. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF248548; AAF86960.1; -; mRNA.
DR   EMBL; AJ292243; CAC21602.1; -; mRNA.
DR   EMBL; BC064651; AAH64651.1; -; mRNA.
DR   RefSeq; NP_114192.1; NM_031986.1.
DR   PDB; 5A2P; X-ray; 2.50 A; A/B/C/D=112-274.
DR   PDB; 5G1D; X-ray; 2.81 A; A/B=108-300.
DR   PDB; 5G1E; X-ray; 1.92 A; A/B=108-300.
DR   PDB; 6AK2; X-ray; 1.87 A; A/B=113-193.
DR   PDB; 8HU2; X-ray; 1.60 A; A=113-274.
DR   PDBsum; 5A2P; -.
DR   PDBsum; 5G1D; -.
DR   PDBsum; 5G1E; -.
DR   PDBsum; 6AK2; -.
DR   PDBsum; 8HU2; -.
DR   AlphaFoldDB; Q9JI92; -.
DR   SMR; Q9JI92; -.
DR   BioGRID; 249867; 8.
DR   IntAct; Q9JI92; 10.
DR   MINT; Q9JI92; -.
DR   STRING; 10116.ENSRNOP00000013563; -.
DR   iPTMnet; Q9JI92; -.
DR   PhosphoSitePlus; Q9JI92; -.
DR   SwissPalm; Q9JI92; -.
DR   jPOST; Q9JI92; -.
DR   PaxDb; 10116-ENSRNOP00000013563; -.
DR   Ensembl; ENSRNOT00000115856.1; ENSRNOP00000081603.1; ENSRNOG00000009683.8.
DR   GeneID; 83841; -.
DR   KEGG; rno:83841; -.
DR   UCSC; RGD:621497; rat.
DR   AGR; RGD:621497; -.
DR   CTD; 6386; -.
DR   RGD; 621497; Sdcbp.
DR   eggNOG; KOG0849; Eukaryota.
DR   GeneTree; ENSGT00940000154502; -.
DR   HOGENOM; CLU_059870_0_0_1; -.
DR   InParanoid; Q9JI92; -.
DR   OMA; NHIVKNM; -.
DR   OrthoDB; 5395964at2759; -.
DR   PhylomeDB; Q9JI92; -.
DR   TreeFam; TF327131; -.
DR   Reactome; R-RNO-3928664; Ephrin signaling.
DR   Reactome; R-RNO-447043; Neurofascin interactions.
DR   Reactome; R-RNO-5213460; RIPK1-mediated regulated necrosis.
DR   Reactome; R-RNO-5675482; Regulation of necroptotic cell death.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:Q9JI92; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000009683; Expressed in lung and 20 other cell types or tissues.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005895; C:interleukin-5 receptor complex; ISS:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:RGD.
DR   GO; GO:0046875; F:ephrin receptor binding; IPI:RGD.
DR   GO; GO:0005109; F:frizzled binding; ISO:RGD.
DR   GO; GO:0019838; F:growth factor binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0005137; F:interleukin-5 receptor binding; ISS:UniProtKB.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IPI:RGD.
DR   GO; GO:0042043; F:neurexin family protein binding; IPI:RGD.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0140311; F:protein sequestering activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0045545; F:syndecan binding; IPI:RGD.
DR   GO; GO:0002091; P:negative regulation of receptor internalization; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISS:UniProtKB.
DR   GO; GO:1903543; P:positive regulation of exosomal secretion; ISO:RGD.
DR   GO; GO:1903553; P:positive regulation of extracellular exosome assembly; ISO:RGD.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; ISO:RGD.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0099054; P:presynapse assembly; IDA:SynGO.
DR   GO; GO:0007265; P:Ras protein signal transduction; ISO:RGD.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; ISS:UniProtKB.
DR   CDD; cd00992; PDZ_signaling; 2.
DR   Gene3D; 2.30.42.10; -; 2.
DR   InterPro; IPR051230; APP-Binding.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   PANTHER; PTHR12345; SYNTENIN RELATED; 1.
DR   PANTHER; PTHR12345:SF10; SYNTENIN-1; 1.
DR   Pfam; PF00595; PDZ; 2.
DR   SMART; SM00228; PDZ; 2.
DR   SUPFAM; SSF50156; PDZ domain-like; 2.
DR   PROSITE; PS50106; PDZ; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell junction; Cell membrane; Cytoplasm;
KW   Cytoskeleton; Endoplasmic reticulum; Lipid-binding; Membrane; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Secreted.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O00560"
FT   CHAIN           2..300
FT                   /note="Syntenin-1"
FT                   /id="PRO_0000184003"
FT   DOMAIN          116..195
FT                   /note="PDZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          200..274
FT                   /note="PDZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          2..104
FT                   /note="Interaction with PDCD6IP"
FT                   /evidence="ECO:0000250|UniProtKB:O08992"
FT   MOTIF           3..7
FT                   /note="LYPX(n)L motif 1"
FT                   /evidence="ECO:0000250|UniProtKB:O08992"
FT   MOTIF           47..51
FT                   /note="LYPX(n)L motif 2"
FT                   /evidence="ECO:0000250|UniProtKB:O08992"
FT   MOTIF           51..55
FT                   /note="LYPX(n)L motif 3"
FT                   /evidence="ECO:0000250|UniProtKB:O08992"
FT   BINDING         252..253
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-4,5-bisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58456"
FT                   /evidence="ECO:0000250|UniProtKB:O00560"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:O00560"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         48
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:O00560"
FT   STRAND          115..120
FT                   /evidence="ECO:0007829|PDB:6AK2"
FT   STRAND          123..125
FT                   /evidence="ECO:0007829|PDB:5A2P"
FT   STRAND          129..133
FT                   /evidence="ECO:0007829|PDB:6AK2"
FT   STRAND          138..143
FT                   /evidence="ECO:0007829|PDB:6AK2"
FT   STRAND          145..147
FT                   /evidence="ECO:0007829|PDB:5A2P"
FT   HELIX           148..151
FT                   /evidence="ECO:0007829|PDB:6AK2"
FT   STRAND          159..163
FT                   /evidence="ECO:0007829|PDB:6AK2"
FT   HELIX           173..180
FT                   /evidence="ECO:0007829|PDB:6AK2"
FT   STRAND          187..193
FT                   /evidence="ECO:0007829|PDB:6AK2"
FT   STRAND          199..204
FT                   /evidence="ECO:0007829|PDB:5G1E"
FT   STRAND          213..216
FT                   /evidence="ECO:0007829|PDB:5G1E"
FT   STRAND          219..223
FT                   /evidence="ECO:0007829|PDB:5G1E"
FT   HELIX           228..231
FT                   /evidence="ECO:0007829|PDB:5G1E"
FT   STRAND          236..247
FT                   /evidence="ECO:0007829|PDB:5G1E"
FT   HELIX           253..261
FT                   /evidence="ECO:0007829|PDB:5G1E"
FT   STRAND          265..273
FT                   /evidence="ECO:0007829|PDB:5G1E"
FT   HELIX           274..280
FT                   /evidence="ECO:0007829|PDB:5G1E"
SQ   SEQUENCE   300 AA;  32423 MW;  F52D8918DE17F710 CRC64;
     MSLYPSLEDL KVDKVIQAQT ASSANPASQA FFLNVVDSAA FPPGGNLYPK LYPELSQYMG
     LSLSEAEICE NMPVVSGAPT QGQLVARPSS VNYMVAPVTG NDAGIRRAEI KQGIREVILC
     KDQDGKIGLR LKSVDNGIFV QLVQANSPAS LVGLRFGDQV LQINGENCAG WSSDKAHKVL
     KQAFGEKITM TIRDRPFERT VTMHKDSSGH VGFIFKSGKI TSIVKDSSAA RNGLLTDHHI
     CEINGQNVIG LKDAQIADIL STAGTVVTIT IMPAFIFEHI IKRMAPSIMK SLMDHTIPEV
//
